ABBV.BA - AbbVie Inc.
NEXT EARNINGS:
Apr 23, 2026
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
Market Cap:
585.00T
Volume:
2,683
Avg Volume:
1,470
52 Week Range:
18750-38540
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Beta:
0.33
Last Dividend:
$927.27
Exchange:
BUE
Country:
US
Employees:
55,000
IPO Date:
2022-06-22
EPS (TTM):
0.21
P/E Ratio:
8.37
Revenue (TTM):
52.48B
Total Assets:
133.98B
Total Debt:
69.08B
Cash & Equiv:
5.23B
Rev Growth (5Y):
11.1%
EPS Growth (5Y):
-14.7%
FCF Growth (5Y):
6.9%
ROCE:
8.7%
Debt/Equity:
20.19
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-01-29 | $99.49 | — | — | $11.5T | — | — |
| 2025-10-28 | $0.01 | — | — | $15.8T | — | — |
| 2025-07-28 | $652.37 | — | — | $19.0T | $15.6T | +21.9% |
| 2025-04-25 | $782.75 | — | — | $14.4T | $14.8T | -2.6% |
| 2025-01-31 | $-12.81 | — | — | $15.6T | $12.9T | +20.3% |
| 2024-10-30 | $855.38 | — | — | $14.0T | — | — |
| 2024-07-25 | $704.73 | — | — | $13.2T | — | — |
| 2024-04-26 | $662.10 | — | — | $10.6T | — | — |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 52.48B | 56.33B | 54.32B | 58.05B | 56.20B | 45.80B | 33.27B | 32.75B | 28.22B | 25.64B | 22.86B | 19.96B |
| Net Income | 3.63B | 4.28B | 4.86B | 11.84B | 11.54B | 4.62B | 7.88B | 5.69B | 5.31B | 5.95B | 5.14B | 1.77B |
| EPS | 0.21 | 2.40 | 2.73 | 6.69 | 6.53 | 2.62 | 5.33 | 3.85 | 3.33 | 3.74 | 3.20 | 1.11 |
| Total Assets | 133.98B | 135.16B | 134.71B | 138.81B | 146.53B | 150.56B | 89.11B | 59.35B | 70.79B | 66.10B | 53.05B | 27.55B |
| Total Debt | 69.08B | 67.14B | 59.38B | 63.27B | 76.68B | 86.06B | 66.73B | 40.31B | 37.37B | 36.84B | 31.67B | 15.01B |
| Cash & Equivalents | 5.23B | 5.52B | 12.81B | 9.20B | 9.75B | 8.45B | 39.92B | 7.29B | 9.30B | 5.10B | 8.40B | 8.35B |
| Operating Cash Flow | 16.33B | 18.81B | 22.84B | 24.94B | 22.78B | 17.59B | 13.32B | 13.43B | 9.96B | 7.04B | 7.54B | 3.55B |
| Free Cash Flow | 15.29B | 17.83B | 22.06B | 24.25B | 21.99B | 16.79B | 12.77B | 12.79B | 9.43B | 6.56B | 7.00B | 2.94B |
| FCF per Share | 0.86 | 10.10 | 12.49 | 13.69 | 12.44 | 9.51 | 8.64 | 8.65 | 5.92 | 4.12 | 4.35 | 1.85 |
| Book Value | (3.27B) | 3.33B | 10.36B | 17.25B | 15.41B | 13.08B | (8.17B) | (8.45B) | 5.10B | 4.64B | 3.94B | 1.74B |
| Cash & ST Investments | 5.26B | 5.55B | 12.82B | 9.23B | 9.83B | 8.48B | 39.92B | 8.06B | 9.79B | 6.42B | 8.41B | 8.37B |
| ROC Equity | N/A | 1.29 | 0.47 | 0.69 | 0.75 | 0.35 | N/A | N/A | 1.04 | 1.28 | 1.30 | 1.02 |